Cholesterol Testing Services Market, By Service Type (Total Cholesterol Test, LDL Cholesterol Test, HDL Cholesterol Test, Triglyceride Test, and Others), By Age Group (Geriatric, Adults, and Pediatric), By Service Provider (Diagnostic Centers, Hospitals,

Cholesterol Testing Services Market, By Service Type (Total Cholesterol Test, LDL Cholesterol Test, HDL Cholesterol Test, Triglyceride Test, and Others), By Age Group (Geriatric, Adults, and Pediatric), By Service Provider (Diagnostic Centers, Hospitals, Ambulatory Care Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

The global cholesterol testing services market was valued US$ 21.60 Bn in 2023 and is expected to reach US$ 39.66 Bn by 2031 growing at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

Figure 1. Global Cholesterol Testing Services Market Share (%), by Region, 2023

Cholesterol testing services have become increasingly important in recent years owing to the rising prevalence of cardiovascular diseases worldwide. As per studies, high levels of cholesterol, especially low-density lipoprotein (LDL) or bad cholesterol, are one of the major risk factors for heart attacks and strokes. Cholesterol testing helps in the screening and diagnosis of high cholesterol levels which often have no visible symptoms. It is recommended for adults to get their cholesterol tested at least once in every 5 years to monitor levels. Various types of cholesterol tests, such as complete lipid panel, lipoprotein analysis, etc., are available which can be performed at laboratories as well as diagnostic centers and clinics. An accurate cholesterol test result serves as an important indicator of potential heart disease risks and helps healthcare providers develop targeted cholesterol management plans through lifestyle changes and medication if required.

Market Dynamics:

The global cholesterol testing services market is driven by the rising geriatric population prone to heart ailments, growing awareness about the benefits of regular health checkups and screening, and increasing focus on preventive healthcare. However, limited healthcare budgets in developing nations and lack of awareness in remote areas continue to restrain the market growth to some extent. However, with increasing investments in research and development activities, increased demand for home-based cholesterol testing kits due to the pandemic, integration of digital technologies to improve diagnostic accuracy and turnaround time, and strategic collaborations between market players and healthcare providers, these challenges are expected to be addressed, thereby opening up new opportunities for market players.

Key Features of the Study:

• This report provides an in-depth analysis of the global cholesterol testing services market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cholesterol testing services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Quest Diagnostics Incorporated, Spectra Laboratories Inc., Bio-Reference Laboratories Inc., Eurofins Scientific (Luxembourg), Clinical Reference Laboratory, Inc. (CRL), ACM Medical Laboratory, Adicon Clinical Laboratory, Unilabs, SYNLAB International GmbH, and Laboratory Corporation of America Holdings (LabCorp), Bioscientia, CML Healthcare, and LloydsPharmacy
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cholesterol testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholesterol testing services market

Detailed Segmentation:

• By Service Type
• Total Cholesterol Test
• LDL Cholesterol Test
• HDL Cholesterol Test
• Triglyceride Test
• Others
• By Age Group
• Geriatric
• Adults
• Pediatric
• By Service Provider
• Diagnostic Centers
• Hospitals
• Ambulatory Care Centers
• Others
• By Region
• North America

 U.S.

 Canada

• Europe

 U.K.

 Germany

 Italy

 France

 Spain

 Russia

 Rest of Europe

• Asia Pacific

 China

 India

 Japan

 ASEAN

 Australia

 South Korea

 Rest of Asia Pacific

• Latin America

 Brazil

 Mexico

 Argentina

 Rest of Latin America

• Middle East & Africa

 GCC

 Israel

 Rest of Middle East

 North Africa

 Central Africa

 South Africa

• Top Companies in the global cholesterol testing services market
• Quest Diagnostics Incorporated
• Spectra Laboratories Inc.
• Bio-Reference Laboratories Inc.
• Eurofins Scientific
• Clinical Reference Laboratory, Inc.
• ACM Medical Laboratory
• Adicon Clinical Laboratory
• Unilabs
• SYNLAB International GmbH
• Laboratory Corporation of America Holdings (LabCorp)
• Bioscientia
• CML Healthcare
• LloydsPharmacy